Announced Mon, 20 Jul · 10:51 IST
Board to consider Q1 results and interim dividend on 30 July
Corporate Actions View source PDF
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.8%1-day move
₹3410.00
prior close
₹3447.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.2+0.3+0.6+4.8+1.2+0.6-1.1-0.7—————
Up moveDown movePending
AI summary
Ajanta Pharma has informed BSE that its Board meeting on 30 July 2026 will consider unaudited Q1 FY27 financial results (quarter ended 30 June 2026) and declaration of the 1st interim dividend for FY ending 31 March 2027. Record date fixed as Wednesday, 5 August 2026 for the interim dividend, if declared.
Likely market impact
Positive signal for income investors. Dividend amount and stock reaction will depend on what the Board actually declares on 30 July.